Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Sean McGarry
CEO of RapidPulse, based in Georgia
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 24 Aug, 2022
"update inverses"
Golden AI
edited on 24 Aug, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
CEO of
RapidPulse
0
Edits on 10 Aug, 2022
"Infobox creation from: https://mobile.twitter.com/dragonsmith42"
Golden AI
edited on 10 Aug, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Location
Atlanta
"Edit from table cell"
godwinno feliks
edited on 10 Aug, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Twitter URL
https://mobile.twitter.com/dragonsmith42
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-150
properties)
Infobox
Patent primary examiner of
US Patent 7098190 Formulations comprising antisense nucleotides to connexins
US Patent 7101714 Molecules of the card-related protein family and uses thereof
US Patent 7119077 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
US Patent 7122527 Use of antisense oligonucleotides to inhibit the expression of human Akt-1
US Patent 7132530 Antisense modulation of superoxide dismutase 1, soluble expression
US Patent 7135312 Circular DNA vectors for synthesis of RNA and DNA
US Patent 7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
US Patent 7144714 R2D2: an enzyme of RNA silencing
US Patent 7148342 Compositions and methods for sirna inhibition of angiogenesis
US Patent 7153948 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
US Patent 7163927 Antisense modulation of kinesin-like 1 expression
US Patent 7173015 Inhibition of Syk kinase expression
US Patent 7176303 Modulation of STAT5 expression
US Patent 7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof
US Patent 7196184 Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
US Patent 7199107 Antisense modulation of kinesin-like 1 expression
US Patent 7199228 Oligonucleotide compositions and their use to induce apoptosis
US Patent 7202357 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US Patent 7205283 Antisense oligonucleotides that inhibit expression of HIF-1
US Patent 7211380 Physiologically active polypeptide and DNA
US Patent 7214525 Pesticidal agents
US Patent 7214766 Peptides with enhanced stability to protease degradation
US Patent 7217517 Nucleic acids, polypeptides, and methods for modulating apoptosis
US Patent 7220853 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
US Patent 7227014 Antisense modulation of apolipoprotein (a) expression
US Patent 7229974 G cap-stabilized oligonucleotides
US Patent 7229976 Modulation of forkhead box O1A expression
US Patent 7235654 Methods for modulating IKKα activity
US Patent 7238675 Antisense antibacterial method and composition
US Patent 7241618 Expression system
US Patent 7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
US Patent 7256284 Inhibitory oligonucleotides targeted to Bcl-2
US Patent 7262175 Synthetic oligonucleotides as inducers of erythroid differentiation
US Patent 7265214 Germinal center kinase proteins, compositions and methods of use
US Patent 7268121 Suppression of nuclear factor-κB dependent processes using oligonucleotides
US Patent 7285288 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US Patent 7288530 Antisense modulation of survivin expression
US Patent 7291725 Sos1 inhibitors
US Patent 7303867 Method for detecting target nucleotide sequences
US Patent 7309695 Pharmaceutical compositions for the prevention and treatment of atherosclerosis and restenosis after PTCA
US Patent 7309786 Oligonucleotide antagonist for human tumor necrosis factor α (TNF-α)
US Patent 7312325 RNA aptamers and methods for identifying the same
US Patent 7320964 Modulation of expression of STAT-1 dependent genes
US Patent 7320965 Compositions and methods for inhibiting expression of Huntingtin gene
US Patent 7323439 Methods and compositions for modulating angiogenesis
US Patent 7326693 Antisense modulation of c-reactive protein expression
US Patent 7332270 Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US Patent 7335764 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US Patent 7339051 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
US Patent 7345027 Compositions and methods for siRNA inhibition of angiogenesis
US Patent 7371850 Method and composition for reducing expression of ROCK-II
US Patent 7375212 Modulation of Aurora B expression
US Patent 7381543 TAB1 protein and DNA coding therefore
US Patent 7381819 Composition for treatment or prevention of endometrial cancer and method of preventing or treating endometrial cancer using the composition
US Patent 7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
US Patent 7396922 Regulation of hypoxia-inducible gene expression with antisense Inhibitory PAS domain protein
US Patent 7399853 Modulation of glucagon receptor expression
US Patent 7414034 Treatment of Parkinson's disease with oligonucleotides
US Patent 7422853 RNA interference using a universal target
US Patent 7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
US Patent 7423141 Inhibitors of endothelin-1 synthesis
US Patent 7425545 Modulation of C-reactive protein expression
US Patent 7427470 Antisense modulation of helicase-moi expression
US Patent 7429648 IREN protein, its preparation and use
US Patent 7452987 Interfering RNA molecules
US Patent 7473525 Compositions and methods for inhibiting expression of anti-apoptotic genes
US Patent 7494981 Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors
US Patent 7507809 RNAi modulation of RSV and therapeutic uses thereof
US Patent 7514549 Tumor inhibition by modulating sprouty expression or activity
US Patent 11186838 LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling
US Patent 7517644 Method and compositions for cellular reprogramming
US Patent 7547511 Antisense inhibition of laminin-8 expression to inhibit human gliomas
US Patent 7582615 Antisense antiviral compound and method for treating arenavirus infection
US Patent 7585966 Inhibitory polynucleotides directed against the RNA component of telomerase
US Patent 7585968 Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)
US Patent 7589189 Inhibition of the expression of huntingtin gene
US Patent 7592318 88kDa tumorigenic growth factor and antagonists
US Patent 7598227 Modulation of apolipoprotein C-III expression
US Patent 7605251 Compositions and methods for inhibiting expression of the PCSK9 gene
US Patent 7608698 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
US Patent 7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
US Patent 7635763 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
US Patent 7638621 siRNA targeting insulin-like growth factor 1 receptor (IGF-1R)
US Patent 7638622 SiRNA targeting intercellular adhesion molecule 1 (ICAM1)
US Patent 7645869 siRNA targeting spleen tyrosine kinase
US Patent 7645870 siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10)
US Patent 7645871 Tumor inhibition by modulating sprouty expression of activity
US Patent 7655788 siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)
US Patent 7662793 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter
US Patent 7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1
US Patent 7671037 Hypoxia induced mitogenic factor
US Patent 7674895 Compositions and methods for siRNA inhibition of angiogenesis
US Patent 7678895 Antisense modulation of superoxide dismutase 1, soluble expression
US Patent 7683165 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7683166 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7691997 Functional and hyperfunctional siRNA
US Patent 7691999 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7696180 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1)
US Patent 7696343 Method for opening tight junctions
US Patent 7718629 Compositions and methods for inhibiting expression of Eg5 gene
US Patent 7741469 Compositions for treating hearing loss and methods of use thereof
US Patent 7745419 Pharmaceutical composition for treating cancer
US Patent 7749978 Compositions and methods for inhibiting expression of Huntingtin gene
US Patent 7750141 Modulation of apolipoprotein c-III expression
US Patent 7759320 Compositions and methods for inhibiting expression of a gene from the Ebola
US Patent 7803932 Compositions and methods for inhibiting EB-1-mediated microtubule stability
US Patent 7812002 Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
US Patent 7816335 Therapeutic compounds and methods
US Patent 7825098 Methods and compositions for modulating Necdin function
US Patent 7829545 Method of treating bladder and lower urinary tract syndromes
US Patent 7838268 Methods for modulating IKKα activity
US Patent 7842673 Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
US Patent 7847090 Compositions and methods for siRNA inhibition of ICAM-1
US Patent 7851616 Development of asthma therapy with rAAV-mediated AMCase shRNA
US Patent 7855183 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
US Patent 7855283 Antisense antiviral compound and method for treating arenavirus infection
US Patent 7858312 Method of treating bladder and lower urinary tract syndromes
US Patent 7871983 Remedy and preventive for diseases caused by NF-κB
US Patent 7871985 Compositions and methods for inhibiting expression of factor VII gene
US Patent 7888120 Global regulator of morphogenesis and pathogenicity in dimorphic fungi and uses thereof
US Patent 7893247 siRNA targeting spleen tyrosine kinase
US Patent 7897755 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
US Patent 7897756 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7902163 Antisense modulation of superoxide dismutase 1, soluble expression
US Patent 7902166 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same
US Patent 7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA
US Patent 7910724 RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)
US Patent 7910725 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7923549 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
US Patent 7927792 Targeted double stranded RNA mediated cell killing
US Patent 7928219 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)
US Patent 7951933 CD38 splice variants and uses thereof
US Patent 7951935 siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
US Patent 7956044 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same
US Patent 7960540 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US Patent 7973016 Methods of treating, reducing, or preventing autoimmune conditions
US Patent 7973020 Compositions and methods for inhibiting expression of a gene from the ebola virus
US Patent 7981868 Antisense modulation of p38 mitogen activated protein kinase expression
US Patent 7981869 RNAi modulation of RSV and therapeutic uses thereof
US Patent 7985581 Multiple RNA polymerase III promoter expression constructs
US Patent 7985853 RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
US Patent 7989613 Inhibition of metallo-β-lactamase by RNA
US Patent 8003620 Compositions and their uses directed to diacylglycerol acyltransferase 1
US Patent 8003781 Composition for suppressing the expression of fucosyltransferase
US Patent 8008272 Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon
US Patent 8008469 Antisense compound for inducing immunological tolerance
US Patent 8008471 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
US Patent 8008472 RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
US Patent 8008473 RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
US Patent 8012947 Methods and compositions for promoting wound healing
Edits on 13 Dec, 2021
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8012947 Methods and compositions for promoting wound healing
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008473 RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008472 RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008471 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008469 Antisense compound for inducing immunological tolerance
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008272 Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8003781 Composition for suppressing the expression of fucosyltransferase
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8003620 Compositions and their uses directed to diacylglycerol acyltransferase 1
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7989613 Inhibition of metallo-β-lactamase by RNA
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7985853 RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7985581 Multiple RNA polymerase III promoter expression constructs
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7981869 RNAi modulation of RSV and therapeutic uses thereof
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7981868 Antisense modulation of p38 mitogen activated protein kinase expression
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7973020 Compositions and methods for inhibiting expression of a gene from the ebola virus
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7973016 Methods of treating, reducing, or preventing autoimmune conditions
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960540 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
Load more
Find more people like Sean McGarry
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE